Severe neurological crisis in adult patients with Tyrosinemia type 1

Severe neurological crisis in adult patients with Tyrosinemia type 1

Abstract We report six adult patients with Tyrosinaemia type 1 (HT‐1) who presented with recurrent porphyria‐like neurological crises after discontinuation/interruption of 2‐(2‐nitro‐4‐trifluoro‐methylbenzyol)‐1,3 cyclohexanedione (NTBC) treatment. The crises were life‐threatening for some of the pa...

Full description

Bibliographic Details
Main Authors:	Charlotte Dawson, Radha Ramachandran, Samreen Safdar, Elaine Murphy, Orlando Swayne, Jonathan Katz, Philip N. Newsome, Tarekegn Geberhiwot
Format:	Article
Language:	English
Published:	Wiley 2020-09-01
Series:	Annals of Clinical and Translational Neurology
Online Access:	https://doi.org/10.1002/acn3.51160

Similar Items

A Case Report of a Very Rare Association of Tyrosinemia type I and Pancreatitis Mimicking Neurologic Crisis of Tyrosinemia Type I
by: Habibe Koç Uçar, et al.
Published: (2016-06-01)

Type 1 Tyrosinemia in an infant
by: Pablo Antonio Hernández Dinza, et al.
Published: (2018-12-01)

Peripheral Neuropathy and Hereditary Tyrosinemia
by: J Gordon Millichap
Published: (1990-03-01)

Tirosinemia neonatal Neonatal tyrosinemia
by: Rafael J. Manotas Cabarcas, et al.
Published: (1995-04-01)

Syndrome of hereditary tyrosinemia in mink
by: Sørensen H, et al.
Published: (1978-10-01)

Hereditary tyrosinemia type 1 in children
by: G. V. Volynets, et al.
Published: (2019-11-01)

Comment on Pancreatitis in Type 1 Tyrosinemia
by: Hakim Rahmoune, et al.
Published: (2017-08-01)

Tyrosinemia type III in an asymptomatic girl
by: Edyta Szymanska, et al.
Published: (2015-12-01)

Tyrosinemia Type I and Reversible Neurogenic Crisis After a One-Month Interruption of Nitisinone
by: Havva Yazıcı, et al.
Published: (2018-03-01)

HPD degradation regulated by the TTC36-STK33-PELI1 signaling axis induces tyrosinemia and neurological damage
by: Yajun Xie, et al.
Published: (2019-09-01)

Neonatal hyperinsulinism in transient and classical forms of tyrosinemia
by: Swathi Sethuram, et al.
Published: (2021-04-01)

Treatment adherence in tyrosinemia type 1 patients
by: Domingo González-Lamuño, et al.
Published: (2021-06-01)

Protein Degradation and the Pathologic Basis of Phenylketonuria and Hereditary Tyrosinemia
by: Neha Sarodaya, et al.
Published: (2020-07-01)

Type 1 tyrosinemia in Finland: a nationwide study
by: Linnea Äärelä, et al.
Published: (2020-10-01)

Type 1 Tyrosinemia with Hypophosphatemic Rickets; a Case Report
by: Peyman Eshraghi, et al.
Published: (2014-09-01)

Girl With Tyrosinemia Type 1 and Executive Dysfunctions Treated With Methylphenidate
by: Annik Simons MD, et al.
Published: (2018-07-01)

The Incidence of Transient Neonatal Tyrosinemia Within a Mexican Population
by: Alexandra V. Zea-Rey MD, et al.
Published: (2017-11-01)

Casein Glycomacropeptide: An Alternative Protein Substitute in Tyrosinemia Type I
by: Anne Daly, et al.
Published: (2021-09-01)

Tyrosinemia type I: clinical and biochemical analysis of patients in Mexico
by: Cynthia Fernández-Lainez, et al.
Published: (2014-03-01)

Biomarkers of Micronutrients in Regular Follow-Up for Tyrosinemia Type 1 and Phenylketonuria Patients
by: Kimber van Vliet, et al.
Published: (2019-08-01)

Therapeutic Targeting of Fumaryl Acetoacetate Hydrolase in Hereditary Tyrosinemia Type I
by: Jon Gil-Martínez, et al.
Published: (2021-02-01)

TYROSINEMIA TYPE III: A CASE REPORT OF SIBLINGS AND LITERATURE REVIEW
by: Fábio Barroso, et al.

Clinical and para clinical findings in the children with tyrosinemia referring for liver transplantation
by: Seyed Mohsen Dehghani, et al.
Published: (2013-01-01)

A Case of Tyrosinemia Type III with Status Epilepticus and Mental Retardation
by: Reza Najafi, et al.
Published: (2018-01-01)

Autism Symptoms Related to Tyrosinemia Type III: A Case Report
by: Ayşegül Yolga Tahiroğlu, et al.
Published: (2008-08-01)

Clinical Features of 29 Patients with Hereditary Tyrosinemia I in Western Turkey
by: Havva Yazıcı, et al.
Published: (2018-03-01)

Photophobia accompanied by painful plantar punctate hyperkeratotic patches: Tyrosinemia type 2
by: Ajay Anand Mohite, et al.
Published: (2018-01-01)

Identification of Novel Mutations in FAH Gene and Prenatal Diagnosis of Tyrosinemia in Indian Family
by: Jayesh J. Sheth, et al.
Published: (2012-01-01)

Clinical utility of nitisinone for the treatment of hereditary tyrosinemia type-1 (HT-1)
by: Das AM
Published: (2017-07-01)

Phenotype, genotype, and outcome of 25 Palestinian patients with hereditary tyrosinemia type 1
by: Imad Dweikat, et al.
Published: (2021-03-01)

Prolonged confusional state as first manifestation of COVID‐19
by: Isabel Butt, et al.
Published: (2020-08-01)

Blood and Brain Biochemistry and Behaviour in NTBC and Dietary Treated Tyrosinemia Type 1 Mice
by: Willem G. van Ginkel, et al.
Published: (2019-10-01)

The molecular basis of the genetic mosaicism in hereditary tyrosinemia (HT1) / Etresia van Dyk
by: Van Dyk, Etresia
Published: (2013)

The molecular basis of the genetic mosaicism in hereditary tyrosinemia (HT1) / Etresia van Dyk
by: Van Dyk, Etresia
Published: (2013)

Design of Polymerase Chain Reaction Initiators and Their Function to Identify FAH Mutations in Type I Tyrosinemia
by: A Keshtkari, et al.
Published: (2019-11-01)

Plantar keratoderma : A manifestation of tyrosinemia type II (<i>Richner-Hanhart syndrome</i>).
by: Al-Ratrout Jihad, et al.
Published: (2005-01-01)

Heat Shock Response Associated with Hepatocarcinogenesis in a Murine Model of Hereditary Tyrosinemia Type I
by: Francesca Angileri, et al.
Published: (2014-04-01)

Neurological teaching in times of crisis
by: Biesalski, Anne-Sophie, et al.
Published: (2020-12-01)

Diagnostic and Therapeutic Challenges of Hereditary Tyrosinemia Type 1 in Lebanon: A 12-Year Retrospective Review
by: Karim N. Daou, et al.
Published: (2021-08-01)

Emotional and behavioral problems, quality of life and metabolic control in NTBC-treated Tyrosinemia type 1 patients
by: Kimber van Vliet, et al.
Published: (2019-12-01)